Abrax Japan Management Team Members

Jo NARITA
CEO
Our co-founder obtained a bachelor's degree in Economics from Johns Hopkins University in the United States. Jo had a successful career as a Managing Director at multiple financial institutions such as Goldman Sachs and Citibank. In 2020, he co-founded our company with Taku Kambayashi and assumed the role of CEO.
Noritake MAEDA
Ph.D, Director
Appointed as a Director at Abrax in 2023.  Yoshitake obtained a PhD in Pharmacy from Kyushu University and has been affiliated with research institutions both domestically and internationally. He has also served as a visiting faculty member at Chiba University and Hokkaido University. After joining Axil Capital, a venture capital firm specializing in biotech, in 2023, he concurrently serves as a Director at Abrax.
Masahiro YAGI
Ph.D, Director
Appointed as a Director at Abrax in 2022 Masahiro obtained a PhD in Mechanical Engineering from the University of Wisconsin-Madison in the United States. He gained experience at research institutes of Hitachi and Ricoh, and had a long and successful career at Ricoh UK. Currently, while leading IDX Holdings as the CEO, he also serves as a Director at Abrax.
David CASE, JD
Legal Adviser
Appointed as the General Counsel at Abrax in 2020. David obtained a Juris Doctor degree magna cum laude from Syracuse University College of Law in the United States. After gaining experience as an equity partner at Orrick LLP, David founded Asia Pacific Law and currently serves as a partner at Rimon Law. Specializing in intellectual property and venture capital.

Abrax Japan Science Team Members

Taku KAMBAYASHI, MD, Ph.D
CSA
Brian KIM, MD, MTR
SA
Peter SHANE, MD
SA
Shinji KAWABATA, MD, Ph.D
SA

Abrax Japan Science Team Members

Thomas BURNS, Ph.D
Director, Public Officer, Abrax Australia Pty. Ltd.
Appointed as a Director at Abrax Australia Pty. Ltd. in 2021. Thomas was affiliated with Dr. Taku Kambayashi's research lab at the University of Pennsylvania. He is responsible for designing and overseeing clinical trials in Australia as a pathway to obtaining FDA approval in the United States.
Jo NARITA
Director, Abrax Australia Pty. Ltd.
Our co-founder obtained a bachelor's degree in Economics from Johns Hopkins University in the United States. Jo had a successful career as a Managing Director at multiple financial institutions such as Goldman Sachs and Citibank. In 2020, he co-founded our company with Taku Kambayashi and assumed the role of CEO.
David CASE, JD
Legal Adviser
Appointed as the General Counsel at Abrax in 2020. David obtained a Juris Doctor degree magna cum laude from Syracuse University College of Law in the United States. After gaining experience as an equity partner at Orrick LLP, David founded Asia Pacific Law and currently serves as a partner at Rimon Law. Specializing in intellectual property and venture capital.